The world’s only regulatory-approved smartphone retinal imaging device demonstrated at DPC 2019
The developers of ‘smart, innovative and disruptive’ imaging technologies, which help to detect an eye-related complication of diabetes were proud to showcase their products at Diabetes Professional Care 2019 (DPC 2019).
Remidio Innovative Solutions is the provider of the world’s first integrated Diabetic Retinopathy Screening solution that supplies an instant report on the presence of Referable Diabetic Retinopathy (RDR) with high accuracy, validated in prospective field trials.
The innovative Integrated Artificial Intelligence-based Ophthalmic Device company seeks to create healthcare access by combining simplicity of product design with cutting edge technology.
Passionate about creating game-changing products in vision-care, the Remidio team focus on the individual needs of customers when implementing new products.
National Head of Sales Diabetology, Saurabh Darda, said: “The solution includes a CE marked and FDA 510k approved non-mydriatic, smartphone-based imaging device and validated Artificial Intelligence solutions that grades for the presence of RDR, right on the smartphone.
“The AI algorithms are CE marked and approved as a Class IIa medical device for use with Remidio Fundus on Phone. Our solutions include interesting, one-of-a-kind technologies such as Offline Artificial Intelligence for the detection of diabetic retinopathy.
“We were very pleased to share some of the most innovative and futuristic ophthalmic screening and diagnostic devices at DPC2019.”
Diabetic retinopathy is a complication of diabetes, caused by high blood sugar levels damaging the back of the eye (retina). It can cause blindness if left undiagnosed and untreated.
Saurabh added: “We are engaged in designing and developing Smart, Innovative & Disruptive Imaging Technologies in Vision Care, using a product development approach called ‘Design Thinking.’ As part of the Design Thinking process, we take into account different facets of a customer’s experience with a product, as part of an overall product design approach, with the intent of inventing a new customer experience with the product.
“We are passionate about Simplifying Healthcare Access using disruptive technologies – we strongly believe this is essential to impact the more than 250 million people at risk worldwide for preventable blindness.”
Remidio is an innovative ISO13485 certified medical device company that seeks to create Healthcare Access using principles of Design Thinking.
For further information about Remidio visit: www.remidio.com